The longtime creative director was instrumental in building the powerhouse agency that is now called FCB Health.
The search giant and the drugmaker will develop new tools to monitor the disease and improve patient outcomes.
Amgen gives hefty discount to Repatha in Europe; Valeant partners with AstraZeneca on controversial psoriasis drug; Pfizer now offers single packages of Viagra
Sales reps that focus on creating value for HCPs could find new opportunities and improved access to those physicians, according to Accenture.
Kim Kardashian posts corrective information on Instagram and Twitter; DPP-4 inhibitors are linked to joint pain; doctors question off-label prescriptions of PCSK9 inhibitors
Amgen's Repatha receives FDA nod; Mylan shareholders vote in favor of Perrigo deal; doctors push for below-average price of experimental cancer drug
Amgen's Repatha will come to market priced $500 lower than the cost of Sanofi and Regeneron's Praluent.
The FDA is expected to announce this week whether it has approved the epilepsy drug as a monotherapy for partial-onset seizures.